Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine

Journal of Infectious Diseases

Volumn 169, Issue 1, 1994, Pages 197-199

  Watson, Barbara ^a   Gupta, Renu ^a   Randall, Thomas ^a   Starr, Stuart ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CHICKENPOX; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; INFANT; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0028154116     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.1.197     Document Type: Article

References (13)

1. Preblud SR. Varicella: Complications and costs. Pediatrics 1982;70: 604-8.
2. Takahashi M, Okuno Y. Otsuka T, et al. Development of a live attenuated varicella vaccine. Biken J 1975;18:25-33.
3. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine. N Engl J Med 1984;310:1410-5.
4. Arbeter AM, Starr SE, Preblud SR, et al. Varicella vaccine trials in healthy children: A summary of comparative and followup studies. Am J Dis Child 1984;138:434-8.
5. Asano Y. Nagai T. Miyata T, et al. Long-term protective immunity of recipients of the OKA strain of varicella vaccine. Pediatrics 1985:75:667-71.
6. Weibel RE. Kuter BJ. Neff BJ. et al. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA 1985;254:2435-9.
7. White CJ. Kuter BJ. Hildebrand CS. et al. Varicella vaccine (Varivax) in healthy children and adolescents: Results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10.
8. Watson B, Piercy S, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993:91:17-22.
9. Arvin AM. Cell-mediated immunity to varicella-zoster virus. J Infect Dis 1992; 166(suppl 1):S35-41.
10. Wasmuth EH, Miller WJ. A sensitive enzyme-linked immuno absorbent assay (ELISA) for antibody to varicella-zoster virus (VZV) using purified VZV glycoprotein antigen. J Med Virol 1990;32:189-93.
11. CLINFO. Cambridge, MA: BBN Corp.. 1987.
12. Hayward AR, Herberger M. Lymphocyte responses to varicella-zoster virus in the elderly. J Clin Immunol 1987;7:174-8.
13. Hardy IB. Gershon AA. Larussa PS. Steinberg SP. The incidence of zoster after immunization with live attenuated varicella vaccine: A study in children with leukemia. N Engl J Med 1991;325:1545-50.